CaMK2 modulators and their use in medicine

Research output: Patent

The present disclosure relates to compounds which bind Ca2+/calmodulin dependent protein kinase II. It also relates to such compounds for use in the treatment of CNS disorders with sleep disturbances and acute brain injury.
Original languageEnglish
IPCA61K31/4164,A61K31/4178,A61P25/00,C07D277/06,C07D277/12,C07D277/56,C07D417/04,C07D417/10
Patent numberWO2023170024A1
Filing date01/01/1970
Country/TerritoryUnited States
Priority numberUS202263318852P
Publication statusPublished - 2023

ID: 382744669